PSD-93 Activators are a class of chemicals that can modulate the activity of PSD-93 through various indirect means, primarily through the modulation of signaling pathways that result in the phosphorylation or dephosphorylation of PSD-93 or its interacting partners. These activators influence a range of biochemical processes, including the adenylate cyclase pathway, phosphodiesterase activity, calcium ion concentration, kinase activity, and even through modulation of neuronal activity. Eachchemical achieves activation by a specific mechanism, such as influencing second messengers like cAMP or cGMP, altering protein kinase or phosphatase activity, or modifying ion concentrations within neurons.
Chemical activators influencing PSD-93, a critical protein in the postsynaptic density, affect synaptic plasticity and neurotransmission without directly binding to PSD-93. They operate by modulating signaling pathways that either add or remove phosphate groups from proteins, a critical mechanism for regulating protein function in cells. For instance, compounds that alter cAMP levels, such as Forskolin and Rolipram, indirectly activate protein kinase A (PKA), which can then phosphorylate PSD-93 or associated proteins. Similarly, ionophores like A23187 and Ionomycin raise intracellular calcium levels, potentially activating calmodulin-dependent kinases (CaMKs) that phosphorylate proteins within the postsynaptic density. Phosphatase inhibitors like Okadaic Acid prevent the dephosphorylation of these proteins, maintaining them in an active state. The functional mechanisms of these activators revolve around altering the phosphorylation status of PSD-93, which can affect its interaction with other synaptic proteins, its localization within the synapse, and its role in synaptic signaling and plasticity. These chemical classes achieve this without binding to the protein itself but by influencing the cellular environment and upstream signaling cascades. Each compound mentioned has been characterized by specific interactions with cellular enzymes or ion channels, leading to a cascade of events culminating in the modification of PSD-93's activity. The specificity of these effects depends on the precise cellular context and the presence of other interacting molecules, which can modulate the outcome of the activator's influence on the protein.
SEE ALSO...
| Product Name | CAS # | Catalog # | QUANTITY | Price | Citations | RATING |
|---|---|---|---|---|---|---|
PMA | 16561-29-8 | sc-3576 sc-3576A sc-3576B sc-3576C sc-3576D | 1 mg 5 mg 10 mg 25 mg 100 mg | $41.00 $132.00 $214.00 $500.00 $948.00 | 119 | |
PMA is a diester of phorbol and is known as a potent activator of protein kinase C (PKC). PSD-93 can be phosphorylated by PKC, which may modulate its activity and interactions with synaptic proteins. Through this pathway, PMA could enhance PSD-93's role in synaptic plasticity. | ||||||
Forskolin | 66575-29-9 | sc-3562 sc-3562A sc-3562B sc-3562C sc-3562D | 5 mg 50 mg 1 g 2 g 5 g | $78.00 $153.00 $740.00 $1413.00 $2091.00 | 73 | |
Forskolin is an activator of adenylate cyclase, leading to an increase in cAMP levels. Higher cAMP levels may activate PKA which can interact with the signaling pathways associated with PSD-93, potentially promoting its phosphorylation and activation. | ||||||
A23187 | 52665-69-7 | sc-3591 sc-3591B sc-3591A sc-3591C | 1 mg 5 mg 10 mg 25 mg | $55.00 $131.00 $203.00 $317.00 | 23 | |
A23187 can increase intracellular calcium concentrations, which can indirectly activate calmodulin-dependent kinases (CaMKs). CaMKs have been shown to phosphorylate proteins in the PSD, potentially influencing PSD-93's activity and synaptic incorporation. | ||||||
Okadaic Acid | 78111-17-8 | sc-3513 sc-3513A sc-3513B | 25 µg 100 µg 1 mg | $291.00 $530.00 $1800.00 | 78 | |
This compound is a potent inhibitor of protein phosphatases 1 and 2A. Inhibition of these phosphatases can lead to increased phosphorylation levels of numerous proteins, potentially including PSD-93, thereby modulating its activity. | ||||||
Rolipram | 61413-54-5 | sc-3563 sc-3563A | 5 mg 50 mg | $77.00 $216.00 | 18 | |
Rolipram inhibits phosphodiesterase 4 (PDE4), leading to increased cAMP levels in neurons and subsequent PKA activation. This could have a downstream effect on PSD-93 phosphorylation and function. | ||||||
Zaprinast (M&B 22948) | 37762-06-4 | sc-201206 sc-201206A | 25 mg 100 mg | $105.00 $250.00 | 8 | |
Zaprinast inhibits phosphodiesterase 5 (PDE5), which could lead to increased cGMP levels and potentially affect signaling pathways that modulate PSD-93's activity. | ||||||